| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 74 | — | 17.8x | Top tier | |
Growth | 16 | 0.6% | 7.1% | Bottom tier | |
Quality | 17 | -0.6% | 4.5% | Bottom tier | |
Safety | 35 | 8.2x | 2.6x | Bottom tier | |
Capital Return | 33 | 4.65% | 2.12% | Bottom tier | |
Momentum | 16 | -20.5% | 2.9% | Bottom tier | |
Sentiment | 62 | 6 | 3 | Around median |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Olin Corporation operates through three interconnected operating pillars: Chlor Alkali Products and Vinyls, Epoxy, and commercial and military Winchester ammunition. The Chlor Alkali Products and Vinyls business relies on sales of caustic soda, chlorine, and their derivatives, including EDC and VCM, while the Epoxy business generates revenue from resins and related products in the United States and Europe. Winchester benefits from commercial ammunition sales, alongside domestic and international military sales and projects.
In fiscal 2026 quarter 2, Olin recorded revenue of $1.7 billion and gross profit of $170.2 million, equivalent to a gross margin of approximately 10.0%, but incurred a net loss of $13.3 million and a loss per share of $0.12. The result improved significantly compared with fiscal 2026 quarter 1, when revenue was $1.6 billion, gross profit was $75.8 million, and the net loss was $83.0 million, but the continued loss confirms that the operating recovery has not yet translated into a net profit.
The operating improvement came from several areas within the mix: Chlor Alkali Products and Vinyls benefited from higher export prices for caustic soda and EDC, Epoxy delivered its best performance in more than three years and returned to profitability, while Winchester's adjusted earnings before interest, taxes, depreciation, and amortization improved, supported by recovering commercial demand and strong military sales. Conversely, the unplanned outage at the VCM facility in Freeport, Texas, reduced adjusted earnings before interest, taxes, depreciation, and amortization by approximately $40 million during the quarter.
Automated analysis for informational purposes only — not investment advice.
The average analyst price target is $23.63, within a wide range of $20 to $31, with a neutral consensus; the average is below the 52-week range high of $30.46, while the highest target is close to that high. No usable price-to-earnings multiple is available while the net loss continues, so the valuation depends more heavily on successful cost reductions, recovery in operating earnings, and a reduction in leverage of approximately 4.5 times expected at the end of fiscal 2026, alongside execution of the Huntsman merger and its targeted savings.
Figures in the text are as of 2026-09-01; the live price is shown at the top of the page.
Olin operates through Chlor Alkali Products and Vinyls, Epoxy, and Winchester commercial and military ammunition. In fiscal 2026 quarter 2, the chemicals business benefited from higher caustic soda and EDC prices and improved Epoxy product pricing, while recovering commercial demand and strong military sales supported Winchester's results. Epoxy delivered its best performance in more than three years and returned to positive earnings, but the outage at the VCM facility in Freeport reduced adjusted earnings before interest, taxes, depreciation, and amortization by approximately $40 million.
Olin did not return to net profitability, as it recorded a net loss of $13.3 million and a loss per share of $0.12 in fiscal 2026 quarter 2. Nevertheless, the result improved compared with fiscal 2026 quarter 1, which recorded a net loss of $83.0 million and a loss per share of $0.73. Gross profit increased between the two periods from $75.8 million to $170.2 million, narrowing the loss but not eliminating it.
On June 16, 2026, Olin announced a planned merger with Huntsman to create an integrated chemicals company focused on North America with sales exceeding $12 billion. The transaction targets savings of $400 million, and Olin shareholders began voting ahead of the special meeting scheduled for August 25, 2026. Management expects the transaction to close in the first half of fiscal 2027, with pre-closing integration planning beginning during fiscal 2026 quarter 3.
Management expects adjusted earnings before interest, taxes, depreciation, and amortization of between $100 million and $200 million in fiscal 2026 quarter 3. Chemicals earnings are expected to remain approximately stable, with improvement in Chlor Alkali offset by a slight sequential decline in Epoxy due to higher European FIFO costs. The company also expects modest improvement at Winchester, supported by commercial volumes and pricing, while corporate and metals costs remain pressure factors.
Olin ended fiscal 2026 quarter 2 with available liquidity of $1.2 billion, including undrawn capacity under its revolving credit facility, and there are no bond maturities before 2029. Working capital increased by $183 million in the first half of fiscal 2026, including $93 million of legacy litigation reserve payments. The company expects to pay an additional $100 million in the second half of fiscal 2026 and end the year with leverage of approximately 4.5 times, while allocating any excess cash flows to debt reduction.
Beyond250 targets structural cost reductions exceeding $250 million by fiscal 2028, and management says it is increasingly confident that it will exceed this target. In fiscal 2026 alone, the company targets more than $100 million of additional structural savings. New supply agreements in Stade and the closure of the Guarulhos plant contributed to reducing Epoxy costs by more than $50 million annually, while Winchester targets savings of $30 million that management may exceed following the assessment of the Lake City facility.
